11 Sep 2017 --- The US Food and Drug Administration (FDA) has made a statement on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce the risk of peanut allergy. It has responded to a petition for a new claim that states, “for most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age.”
This is the first time the FDA has recognized a qualified health claim to prevent a food allergy. “Our goal is to make sure parents are abreast of the latest science and can make informed decisions about how they choose to approach these challenging issues,” says FDA Commissioner Scott Gottlieb, M.D. in a statement.
Continuing to monitor research The new claim on food labels will recommend that parents check with their infant’s healthcare provider before introducing foods containing ground peanuts. It will also note that the claim is based on one study. The FDA will continue to monitor the research related to peanut allergy and if new scientific information further informs what it knows about peanut allergy, the FDA will evaluate whether the claim should be updated.
Along with the information that the US public currently sees on food labels, which disclose when a food contains peanuts or peanut residue, the new advice about the early introduction to peanuts and reduced risk of developing peanut allergy will soon be found on the labels of some foods containing ground peanuts that are suitable for infant consumption. Whole peanuts, on the other hand, are considered a choking hazard for young children that should not be consumed.
Peanut allergy is considered one of the most common food allergies – and also one of the most dangerous – by the FDA. It is the leading cause of death related to food-induced anaphylaxis in the US. For these reasons, Gottlieb points out, it’s “a cause of significant concern among new parents.”
The majority of inpiduals who are allergic to peanuts developed the allergy early in life and never outgrew it, Gottlieb adds. The prevalence of peanut allergy has more than doubled in children from 1997 to 2008 alone, Gottlieb points out, and about 2 percent of American children are allergic to peanuts.
“As the incidence of peanut allergy grew, along with an awareness of the consequences, doctors began advising parents not to introduce peanut-containing foods to children under the age of three who were at high risk for peanut allergy,” Gottlieb says. “While this advice was well intended, new evidence-based guidelines recommend that the medical community consider a different approach. A recent landmark clinical trial funded by the National Institutes of Health found that introducing foods containing smooth peanut butter to babies as early as 4 months of age who are at high risk of developing a peanut allergy – due to severe eczema or egg allergy or both – reduces their risk of developing peanut allergy later in childhood by about 80 percent.”
“That finding led the NIH to issue new guidelines in January, recommending that parents of infants with severe eczema, egg allergy or both introduce peanut-containing foods into a child’s diet as early as 4 to 6 months of age,” Gottlieb continues. “The guidelines advise parents to check with their infant’s healthcare provider before feeding their baby peanut-containing foods in order to determine whether an allergy test is needed first and whether feeding should be done under a doctor’s supervision.”
“We know that there’s more to learn about food allergies,” Gottlieb concludes. “The more we learn, the better we can consider how best to introduce allergenic foods, as well as prevent and treat food allergies. We need to continue to invest in the science related to our diets. The FDA remains committed to advancing and supporting research and innovations that help lower the rate of food allergies and better protect the public health.”
19 Sep 2017 –
Naturex has signed a global distribution ...
19 Sep 2017 –
Algatechnologies’ organic Haematococcus ...
18 Sep 2017 –
The way in which the markets of sports nutrition ...
18 Sep 2017 –
Scientists at Rutgers University-New Brunswick ...
13 Sep 2017 –
Canadian manufacturer Mazza Innovation Ltd. has ...